Study on adverse effect and efficacy of a human chemokine derivative in combination with radiotherapy for advanced or metastatic malignancy
Phase 1
- Conditions
- Advanced or metastatic malignancy
- Registration Number
- JPRN-UMIN000007681
- Lead Sponsor
- Tokyo Radiation Oncology Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
In pregnancy or during lactation Received steroid hormone now Medication with chemotherapy, radiotherapy, hormone therapy or immunotherapy in the last 4 weeks Autoimmune disease Organ transplantation HIV, hepatitis B/C Uncontrorable complication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor size on CT (at pretreatment and 2 weeks after treatment) Evaluation of DLT(dose limiting toxicity)
- Secondary Outcome Measures
Name Time Method aboratory data(at pretreatment and 2 weeks after treatment)